Product Information
ELIQUIS 2.5 MG TABLET is a brand product labeled by E.R. Squibb & Sons, L.L.C., priced at $5.5161 per EA under NDC 00003089331. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
2.5 mg/1
Manufacturer
E.R. Squibb & Sons, L.L.C.NDC
00003089331
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
APIXABANApproval Type
New Drug (NDA)
FDA Application
NDA202155On Market Since
12/28/2012
Pharmacological Classes
Price Statistics
The NADAC for ELIQUIS 2.5 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 28.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.5161 per EA |
|---|---|
| All-time high | $9.6982 (May 14, 2025) |
| All-time low | $4.2903 (Nov 28, 2013) |
| 52-week high | $9.6896 |
| 52-week low | $5.5160 |
| Median price | $7.1067 |
| Average price | $7.2143 |
| Largest weekly change | -43.0% (Jan 14, 2026) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ELIQUIS 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ELIQUIS 2.5 MG TABLET, manufactured by E.R. Squibb & Sons, L.L.C., is $5.5161 per EA (NDC 00003089331), effective Jun 24, 2026.
How has the price of ELIQUIS 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ELIQUIS 2.5 MG TABLET has risen 28.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ELIQUIS 2.5 MG TABLET?
Since Nov 28, 2013, the NADAC for ELIQUIS 2.5 MG TABLET has ranged from a low of $4.2903 (Nov 28, 2013) to a high of $9.6982 (May 14, 2025), with a median of $7.1067 per EA.
Are there cheaper alternatives to ELIQUIS 2.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ELIQUIS 2.5 MG TABLET, but none are currently priced below it.
Who manufactures ELIQUIS 2.5 MG TABLET?
ELIQUIS 2.5 MG TABLET (NDC 00003089331) is labeled by E.R. Squibb & Sons, L.L.C., and CMS classifies it as a brand product.
Related Drugs
Same classification